Comparison

Multiple Myeloma [MM] vs HemeOncBuddy

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

Multiple Myeloma [MM]

This clinical decision support tool provides healthcare professionals with curated, evidence-based medical content for managing Multiple Myeloma. It uses AI-powered natural language queries to deliver quick, confidence-rated answers, aiding in better patient care and outcomes.

Highlights
  • AI-powered natural language queries
  • Evidence-based medical content
  • Diagnosis, treatment, and care management topics
  • Case studies, videos, and interviews
  • Continuing medical education credit
  • Patient education resources
Features
Read full description

@Point of Care™ With Cognitive AI is a clinical decision-making mobile platform. Multiple Myeloma @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care. With Cognitive AI, clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Cognitive AI, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care. Multiple Myeloma @Point of Care™ is designed to: • Support discovery and practice change • Provide relevant, evidence-based disease-specific medical content • Improve patient outcomes at the point of care Features: • Continually updated Multiple Myeloma content • Topics in diagnosis, treatment, and care management developed with expert physician authors • Case studies, videos, and interviews • Access to actionable patient-recorded data • Detailed reference list with access to original sources • Continuing medical education credit (CME/CE) • Surveys and peer polling • Patient education resources to share with patients

About

HemeOncBuddy

This app provides quick access to practice-changing clinical trials in Hematology and Oncology. It offers simplified summaries of trial background, inclusion/exclusion criteria, primary endpoints, and outcomes for easy reference.

Highlights
  • Practice-changing clinical trial summaries
  • Hematology and Oncology focus
  • Simplified trial information
  • Inclusion and exclusion criteria
  • Primary endpoints and outcomes
  • Quick reference tool
Features
Read full description

HemeOncBuddy is a free study hub built for hematology and oncology fellows and trainees - everything you need to keep up with the literature and prep for boards, in one fast, searchable app. WHAT'S INSIDE - 1,500+ pivotal clinical-trial summaries, each in the same structure (background, inclusion criteria, arms, primary/secondary endpoints, median follow-up, key results, notable toxicities) so you can scan them quickly. - A Question Bank with board-style questions, tutor and timed modes, explanations, and progress tracking. - ~2,000 active-recall flashcards across oncology, malignant and benign heme, and pharmacology — plus visual staging decks. - 120+ concise disease-site board-prep notes. - A conference & abstract-deadline tracker so you never miss a submission window. MADE FOR STUDYING - Full dark mode and adjustable text size. - Optional free account (Sign in with Apple, Google, or email) to sync your saved trials, Qbank progress, and notes across iPhone, iPad, and Mac. - No ads. No paywall. No login required to browse. HemeOncBuddy is an educational study aid only. It is not a substitute for medical advice, clinical judgment, or current guidelines, and must not be used to diagnose or treat patients. Always verify against primary literature and current guidelines.

Screenshots

Multiple Myeloma [MM]4 screens
HemeOncBuddy4 screens

Verdict

The call

Multiple Myeloma [MM] and HemeOncBuddy both sit at 5.0 stars, but that hides the real split: 100% of HemeOncBuddy's written reviews are positive against 50% of Multiple Myeloma [MM]'s. HemeOncBuddy also leads on ratings volume (19 vs 1). Multiple Myeloma [MM]'s advantage is update cadence (every 5 weeks vs every 24 months). On price, rating, ads and in-app purchases there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

ReceptionRating · Positive reviews · Number of ratings

On the App Store both sit at effectively the same score — 5.0 for Multiple Myeloma [MM] against 5.0 for HemeOncBuddy. That said, the two scores are not equally well evidenced: HemeOncBuddy has 19 ratings behind it against 1, so its average is the more settled of the two. Written reviews are what separate them: 50% of Multiple Myeloma [MM]'s written reviews are positive against 100% of HemeOncBuddy's.

UpkeepUpdate frequency

Multiple Myeloma [MM] ships an update every 5 weeks, HemeOncBuddy every 24 months. The most recent releases landed on November 1, 2026 and November 16, 2026 respectively.

Scorecard3 real differences · 7 level
Multiple Myeloma [MM] versus HemeOncBuddy: the parameters behind the verdict, then further details
ParameterMultiple Myeloma [MM]HemeOncBuddy
PriceFreeFree
Rating5.0 (1 ratings)5.0 (19 ratings)
Positive reviews50.0% of reviews100.0% of reviews — better
Number of ratings119 — better
Update frequencyEvery 5 weeks — betterEvery 24 months
AdsNoNo
In-app purchasesNoNo
MonetizationFreeFree
DevicesiPhone, iPad, iPodiPhone, iPad, iPod
Requires iOS14.0 — better15.0
Further details — not scored
Size24 MB16 MB
Age rating12+17+
Developer@Point of CareVeli Bakalov

Customer experience

Multiple Myeloma [MM]

All ratings1 ratings
Positive100.0%
Neutral0.0%
Negative0.0%
Written reviews2 reviews
Positive50.0%
Neutral0.0%
Negative50.0%

HemeOncBuddy

All ratings17 ratings
Positive100.0%
Neutral0.0%
Negative0.0%
Written reviews2 reviews
Positive100.0%
Neutral0.0%
Negative0.0%

In-app purchases

None

Multiple Myeloma [MM]

No in-app purchases

None

HemeOncBuddy

No in-app purchases

Questions

Is Multiple Myeloma [MM] free?
Multiple Myeloma [MM] is free to download, with no in-app purchases.
Is HemeOncBuddy free?
HemeOncBuddy is free to download, with no in-app purchases.
Which has better reviews, Multiple Myeloma [MM] or HemeOncBuddy?
Multiple Myeloma [MM] and HemeOncBuddy are both rated 5.0 out of 5 on the App Store, from 1 and 19 ratings respectively.
Do Multiple Myeloma [MM] or HemeOncBuddy have ads?
Neither Multiple Myeloma [MM] nor HemeOncBuddy shows ads.
Which is updated more often, Multiple Myeloma [MM] or HemeOncBuddy?
Multiple Myeloma [MM] ships an update every 5 weeks, and HemeOncBuddy every 24 months. Most recently, Multiple Myeloma [MM] was updated on November 1, 2026 and HemeOncBuddy on November 16, 2026.

Other comparisons